Key facts
- This page summarizes Michael R. Friedman's Form 3 filing for Peak Bio, Inc..
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Sep 2023, 16:05.
Michael R. Friedman - 25 Aug 2023 Form 3 Insider Report for Peak Bio, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 25 Aug 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 12 Sep 2023, 16:05:09 UTC
- Next SEC filing
- 02 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Friedman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael R. Friedman filed Form 3 for Peak Bio, Inc. on 12 Sep 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PKBO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,692
- Date
- 25 Aug 2023
- Ownership
- Direct
PKBO
holding
Warrant (Right to Purchase)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 35,000
- Date
- 25 Aug 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.